Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

NL: Bedrocan presents new high-CBD raw material

Bedrocan is bringing new opportunities for the nutraceuticals industry at Vitafoods Europe 2025 with its new high-CBD cannabis product. The recently introduced Bedrolina® can be used as biomass for manufacturing different nutraceutical products, including food supplements. The consistent cannabinoid content of Bedrolina® supports cost-effective and high-quality production of CBD-based formulations. The material contains up to 14% CBD and less than 1% THC and is available in cut flos form (ground, dried flower) and in whole-dried flower form.

CBD raw materials
In recent years, CBD products have become popular in nutraceuticals as more jurisdictions regulate CBD across the globe. However, the options for reliable cannabis raw materials with high CBD levels and consistent supply seem limited. This creates a challenge for manufacturers to keep a qualitative production process.

Due to regulatory barriers, hemp varieties are the most common source of supply for manufacturers of CBD-based products, as these contain a maximum of 0.3% THC. According to Bedrocan's CEO, Jaap Erkelens, these hemp-derived raw materials are not the best option for nutraceutical manufacturers: "Hemp varieties often contain a lower CBD percentage, which means that more biomass is needed. In addition, these hemp varieties are not suitable for medicinal applications."

Besides the advantage of using less plant material, manufacturers will also be able to rely on a consistent supply of this non-hemp CBD variety from our new facility in Denmark, an important advantage in a market with growing demand.

Outdoor cultivation
The company has also started an outdoor cultivation project, growing high-CBD and other novel medicinal plants through a partnership in Suriname, which may become another option to supply the nutraceuticals industry in the future, especially in the North and South American regions. Additionally, Bedrocan also presents its contract manufacturing services knowledge transfer to other herbal raw material suppliers at Vitafoods Europe 2025.

For more information:
Bedrocan
www.bedrocan.com